AAVantgarde and AGC Biologics have entered into an agreement in which AGC Biologics will provide Good Manufacturing Practice manufacturing for AAVantgarde’s dual-vector gene therapies for inherited ...
We show here that EBV-based vectors are suitable for transferring the GM-CSF gene into human B cells, including established B-cell lines, resting primary B cells, and tumor B cells from patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback